Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension-Reference-Cited by-同舟云学术

Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension

Published:2005-05-26 Issue:5-6 Volume:61 Page:353-359
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Anan Futoshi,Takahashi Naohiko,Ooie Tatsuhiko,Yufu Kunio,Hara Masahide,Nakagawa Mikiko,Yonemochi Hidetoshi,Saikawa Tetsunori,Yoshimatsu Hironobu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-005-0931-8.pdf

Reference39 articles.

1. Dahlof B, Devereux RB, Kjeldsen SE et al for the LIFE Study Group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995–1003

2. Fox KM (2003) EURopean trial on reduction of cardiac events with perindopril in stable coronary Artery disease investigators: efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782–788

3. Lonn E, Shaikholeslami R, Yi Q et al (2004) Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the heart outcome prevention evaluation (HOPE) Trial. J Am Coll Cardiol 43:2200–2206

4. Stergiou GS, Skeva II, Baibas NM et al (2000) Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension. J Cardiovasc Pharmacol 35:937–941

5. Mogensen CE, Neldam S, Tikkanen I et al (2000) Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study. BMJ 321:1440–1444

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Markers of Vascular Dysfunction in Hypertension;Current Medicinal Chemistry;2024-07-25

2. Comparative Efficacy of Monotherapy of Angiotensin-converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers in Treating Essential Hypertension – A Meta-analysis;Apollo Medicine;2024-04-29

3. KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated with a Greater Recovery of Arterial Stiffness;Cancers;2021-08-26

4. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials;PLOS ONE;2021-07-07

5. Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients;Medicine;2021-06-25